2023-510488-36-01
EU Clinical Trials Information System
- Trial ID
- T-ctis-2023-510488-36-01
- Registry
- EU Clinical Trials Information System
- CTIS number
- 2023-510488-36-01
- Sponsor, as registered
- Universitair Medisch Centrum Groningen
- Phase
- Therapeutic exploratory (Phase II)
- Indication
- Chronic obstructive pulmonary disease (COPD), amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and atypical Parkinson disorder (APD), particularly multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal syndrome (CBS).
- Status
- Authorised
- Start date
- 2025-06-01
- Primary completion
- CTIS does not publish one.
- Member states concerned
- Czechia, Denmark, Netherlands, Portugal
- Sites
- 4
Member states whose regulator has a decision on this trial.
euclinicaltrials.euctis registryverified 2026-11-07
Notes on the record
Supersedes the row verified 2026-09-28 (kept), per DATA LAYER rule 4. Read from the CTIS public API retrieve endpoint 2026-11-07 (https://euclinicaltrials.eu/ctis-public-api/retrieve/2023-510488-36-01; response sha256 c570f57f9b4c). primary_completion_date is EMPTY because CTIS does not publish one. Per-state authorisation is NOT recorded and status codes are recorded verbatim, not decoded: the registry publishes no key. Portugal lastDecisionDate 2026-11-05T13:09:45 (was 2026-06-17); Czechia 2026-06-17, Netherlands 2026-09-22, Denmark 2026-04-28; member states CZ, DK, NL, PT unchanged. The API does not expose what the decision was. Title on the record: PsyPal; Psilocybin Therapy for Psychological Distress in Palliative Patients (the indication column carries the earlier row's text, kept).
Cited in
Issues quoting 2023-510488-36-01 in their own text.